Limiting inflammatory responses during activation of innate immunity

The idea of the importance of mounting an inflammatory response for effective immunity is supported by a multiplicity of experimental data. It is also well understood that resolution of inflammation is essential for maintaining the balance between health and disease. When the normal regulatory mechanisms are disturbed, the potential for developing chronic inflammatory diseases is increased. Inflammation is a key element in the response of the innate immune system to a variety of challenges, including those provided by bacterial and viral infection as well as by damaged or dying host cells. Here we review elements of innate immunity that lead to inflammation and some of the host mechanisms that allow for the resolution of the inflammatory responses.

[1]  N. Mackman,et al.  Dexamethasone enhances LPS induction of tissue factor expression in human monocytic cells by increasing tissue factor mRNA stability , 2004, Journal of leukocyte biology.

[2]  K. Mahtani,et al.  Mitogen-Activated Protein Kinase p38 Controls the Expression and Posttranslational Modification of Tristetraprolin, a Regulator of Tumor Necrosis Factor Alpha mRNA Stability , 2001, Molecular and Cellular Biology.

[3]  P. Anderson,et al.  MK2‐induced tristetraprolin:14‐3‐3 complexes prevent stress granule association and ARE‐mRNA decay , 2004, The EMBO journal.

[4]  J. Tschopp,et al.  MyD88S, a splice variant of MyD88, differentially modulates NF‐κB‐ and AP‐1‐dependent gene expression , 2003, FEBS letters.

[5]  F. Liew,et al.  Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.

[6]  M. Mann,et al.  AU Binding Proteins Recruit the Exosome to Degrade ARE-Containing mRNAs , 2001, Cell.

[7]  Makoto Nakanishi,et al.  A20 Is a Negative Regulator of IFN Regulatory Factor 3 Signaling1 , 2005, The Journal of Immunology.

[8]  G. Kollias,et al.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. , 1999, Immunity.

[9]  G. Stark,et al.  SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling , 2003, Nature Immunology.

[10]  邊見 弘明,et al.  A Toll-like receptor recognizes bacterial DNA , 2003 .

[11]  A. Caudy,et al.  Argonaute2, a Link Between Genetic and Biochemical Analyses of RNAi , 2001, Science.

[12]  Matthew T Wheeler,et al.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.

[13]  A. Dunne,et al.  The Interleukin-1 Receptor/Toll-Like Receptor Superfamily: Signal Transduction During Inflammation and Host Defense , 2000, Science's STKE.

[14]  C. Garlanda,et al.  Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Gaestel,et al.  MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis , 1999, Nature Cell Biology.

[16]  K. Heeg,et al.  Suppressor of Cytokine Signaling (SOCS) Proteins Indirectly Regulate Toll-like Receptor Signaling in Innate Immune Cells*♦ , 2004, Journal of Biological Chemistry.

[17]  S. Foster,et al.  An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.

[18]  K. Heeg,et al.  CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. , 1998, Journal of immunology.

[19]  S. Wahl,et al.  Aberrant Toll Receptor Expression and Endotoxin Hypersensitivity in Mice Lacking a Functional TGF-β1 Signaling Pathway , 2004, The Journal of Immunology.

[20]  S. Stibitz,et al.  Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. , 1999, Journal of immunology.

[21]  P. Rosenstiel,et al.  TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells ☆ ☆☆ ★ ★★ ♢ , 2003 .

[22]  A. Caudy,et al.  A micrococcal nuclease homologue in RNAi effector complexes , 2003, Nature.

[23]  A. Shyu,et al.  RNA stabilization by the AU‐rich element binding protein, HuR, an ELAV protein , 1998, The EMBO journal.

[24]  Liwu Li,et al.  Characterization of Tollip protein upon Lipopolysaccharide challenge. , 2004, Molecular immunology.

[25]  L. New,et al.  Gene suppression by tristetraprolin and release by the p38 pathway. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[26]  P. Cohen,et al.  Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP‐K2 and its interaction with cytokine mRNAs , 2002, The EMBO journal.

[27]  J. Lykke-Andersen,et al.  Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. , 2005, Genes & development.

[28]  Georges Huez,et al.  Identification of TIAR as a Protein Binding to the Translational Regulatory AU-rich Element of Tumor Necrosis Factor α mRNA* , 1999, The Journal of Biological Chemistry.

[29]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[30]  B. Bloom,et al.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.

[31]  J. Bertin,et al.  Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan , 2003, Science.

[32]  Jiahuai Han,et al.  TAB1β (Transforming Growth Factor-β-activated Protein Kinase 1-binding Protein 1β), a Novel Splicing Variant of TAB1 That Interacts with p38α but Not TAK1* , 2003, The Journal of Biological Chemistry.

[33]  Toby Lawrence,et al.  IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.

[34]  M. Chamaillard,et al.  Nods, Nalps and Naip: intracellular regulators of bacterial‐induced inflammation , 2003, Cellular microbiology.

[35]  M. Busslinger,et al.  Alternative promoter usage of the Fos‐responsive gene Fit‐1 generates mRNA isoforms coding for either secreted or membrane‐bound proteins related to the IL‐1 receptor. , 1994, The EMBO journal.

[36]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[37]  F. Liew,et al.  ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance , 2004, Nature Immunology.

[38]  G. Hunninghake,et al.  Phosphatidylinositol 3-Kinase Activity Negatively Regulates Stability of Cyclooxygenase 2 mRNA* , 2002, The Journal of Biological Chemistry.

[39]  Anne Wright,et al.  Cloning and Characterization of HuR, a Ubiquitously Expressed Elav-like Protein (*) , 1996, The Journal of Biological Chemistry.

[40]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[41]  S. Peltz,et al.  Regulated ARE-mediated mRNA decay in Saccharomyces cerevisiae. , 2001, Molecular cell.

[42]  S. Hoffman,et al.  Interleukin-12- and Gamma Interferon-Dependent Protection against Malaria Conferred by CpG Oligodeoxynucleotide in Mice , 2001, Infection and Immunity.

[43]  C. Moroni,et al.  c‐jun N‐terminal kinase is involved in AUUUA‐mediated interleukin‐3 mRNA turnover in mast cells , 1998, The EMBO journal.

[44]  G. Núñez,et al.  The NOD: a signaling module that regulates apoptosis and host defense against pathogens , 2001, Oncogene.

[45]  G. Hartmann,et al.  Combined dendritic cell‐ and CpG oligonucleotide‐based immune therapy cures large murine tumors that resist chemotherapy , 2002, European journal of immunology.

[46]  E. Appella,et al.  Alternative p38 activation pathway mediated by T cell receptor–proximal tyrosine kinases , 2005, Nature Immunology.

[47]  Hao Wu,et al.  TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[48]  K. Vuori,et al.  Phosphatidylinositol 3‐kinase is involved in Toll‐like receptor 4‐mediated cytokine expression in mouse macrophages , 2003, European journal of immunology.

[49]  Michelle R. Arkin,et al.  Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.

[50]  A. Ferrante,et al.  Monocytic Cell Line 15-Hydroperoxyeicosatetraenoic Acid in a TNF mRNA Decay by the Inflammatory Response : Promotion of Cutting Edge : Novel Role of Lipoxygenases in , 2005 .

[51]  R. Cuesta,et al.  Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. , 1999, Science.

[52]  A. Leonardi,et al.  Association of the Adaptor TANK with the IκB Kinase (IKK) Regulator NEMO Connects IKK Complexes with IKKε and TBK1 Kinases* , 2002, The Journal of Biological Chemistry.

[53]  C. Schmidt‐Weber,et al.  Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. , 2004, Current opinion in immunology.

[54]  A. Tarakhovsky,et al.  Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105 , 2005, Nature Immunology.

[55]  A. Manning,et al.  Targeting JNK for therapeutic benefit: from junk to gold? , 2003, Nature Reviews Drug Discovery.

[56]  J. Dean,et al.  p38 Mitogen-activated Protein Kinase Regulates Cyclooxygenase-2 mRNA Stability and Transcription in Lipopolysaccharide-treated Human Monocytes* , 1999, The Journal of Biological Chemistry.

[57]  Shuang Huang,et al.  Involvement of MicroRNA in AU-Rich Element-Mediated mRNA Instability , 2005, Cell.

[58]  A. Masuda,et al.  Cutting Edge: Naturally Occurring Soluble Form of Mouse Toll-Like Receptor 4 Inhibits Lipopolysaccharide Signaling1 , 2000, The Journal of Immunology.

[59]  Rodolfo Marquez,et al.  The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. , 2005, Immunity.

[60]  K. Asadullah,et al.  Interleukin-10 Therapy—Review of a New Approach , 2003, Pharmacological Reviews.

[61]  J. Shabanowitz,et al.  MAPKAP Kinase 2 Phosphorylates Tristetraprolin on in Vivo Sites Including Ser178, a Site Required for 14-3-3 Binding* , 2004, Journal of Biological Chemistry.

[62]  B. Beutler,et al.  Genetic analysis of innate immunity: identification and function of the TIR adapter proteins. , 2005, Advances in experimental medicine and biology.

[63]  D E Griswold,et al.  Inhibition of p38 MAP kinase as a therapeutic strategy. , 2000, Immunopharmacology.

[64]  A. Thatayatikom,et al.  Mutation of a New Gene Encoding a Putative Pyrin-Like Protein Causes Familial Cold Autoinflammatory Syndrome and Muckle-Wells Syndrome , 2002, Pediatrics.

[65]  B. Hemmings,et al.  The ARE‐dependent mRNA‐destabilizing activity of BRF1 is regulated by protein kinase B , 2004, The EMBO journal.

[66]  Michael Karin,et al.  Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing , 2005, Science.

[67]  M. Sweet,et al.  A Novel Pathway Regulating Lipopolysaccharide-Induced Shock by ST2/T1 Via Inhibition of Toll-Like Receptor 4 Expression1 , 2001, The Journal of Immunology.

[68]  G. Stark,et al.  IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.

[69]  C. Sette,et al.  Peptide-mediated Interference of TIR Domain Dimerization in MyD88 Inhibits Interleukin-1-dependent Activation of NF-κB* , 2005, Journal of Biological Chemistry.

[70]  K. Burns,et al.  Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.

[71]  D S Latchman,et al.  Transcription factors as potential targets for therapeutic drugs. , 2000, Current pharmaceutical biotechnology.

[72]  R. Ulevitch,et al.  Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors , 2004, Nature Immunology.

[73]  G. Thomas,et al.  CARD15 mutations in Blau syndrome , 2001, Nature Genetics.

[74]  P. Blackshear,et al.  Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin , 1998 .

[75]  P. Bucher,et al.  The CARD domain: a new apoptotic signalling motif. , 1997, Trends in biochemical sciences.

[76]  S. Koyasu,et al.  PI3K and negative regulation of TLR signaling. , 2003, Trends in immunology.

[77]  John Calvin Reed,et al.  Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. , 2002, Biochemical and biophysical research communications.

[78]  W. Yeh,et al.  IRAK-4 as the central TIR signaling mediator in innate immunity. , 2002, Trends in immunology.

[79]  Jiahuai Han,et al.  MAPKK-Independent Activation of p38α Mediated by TAB1-Dependent Autophosphorylation of p38α , 2002, Science.

[80]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[81]  C. Weston,et al.  The JNK signal transduction pathway. , 2007, Current opinion in genetics & development.

[82]  Sophie Janssens,et al.  Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.

[83]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[84]  L. Lenz,et al.  TRAIL-R as a negative regulator of innate immune cell responses. , 2004, Immunity.

[85]  Michael Karin,et al.  The IKK NF-κB system: a treasure trove for drug development , 2004, Nature Reviews Drug Discovery.

[86]  V. Dixit,et al.  RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. , 1998, The Journal of biological chemistry.

[87]  Marco Colombi,et al.  Functional cloning of BRF1, a regulator of ARE‐dependent mRNA turnover , 2002, The EMBO journal.

[88]  J. Dean,et al.  Post‐transcriptional regulation of gene expression by mitogen‐activated protein kinase p38 , 2003, FEBS letters.

[89]  M. Hardy,et al.  The Murine Irak2 Gene Encodes Four Alternatively Spliced Isoforms, Two of Which Are Inhibitory* , 2004, Journal of Biological Chemistry.

[90]  Warren S. Alexander,et al.  Suppressors of cytokine signalling (SOCS) in the immune system , 2002, Nature Reviews Immunology.

[91]  Govinda Rao,et al.  IRF3 mediates a TLR3/TLR4-specific antiviral gene program. , 2002, Immunity.

[92]  A. Krieg,et al.  Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[93]  A. Ferrante,et al.  Cutting Edge: Novel Role of Lipoxygenases in the Inflammatory Response: Promotion of TNF mRNA Decay by 15-Hydroperoxyeicosatetraenoic Acid in a Monocytic Cell Line 1 , 2005, The Journal of Immunology.

[94]  P. Murray,et al.  Role of Nod2 in the Response of Macrophages to Toll-Like Receptor Agonists , 2003, Molecular and Cellular Biology.

[95]  TylerZARUBIN,et al.  Activation and signaling of the p38 MAP kinase pathway , 2005 .

[96]  E. Goldsmith,et al.  How MAP Kinases Are Regulated (*) , 1995, The Journal of Biological Chemistry.

[97]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[98]  W. Wahli,et al.  PPARs as drug targets to modulate inflammatory responses? , 2004, Current drug targets. Inflammation and allergy.

[99]  P. Young,et al.  Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. , 1997, Biochemical and biophysical research communications.

[100]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.